Founded in 1923 as a wholesaler for dressing materials (pharmacies, drugstores, medical supply), Söhngen is a leading manufacturer and value-added supplier of premium products for wound care, first aid and emergency medicine. With a portfolio of more than 14,000 items, Söhngen offers both standardised as well as individualised solutions for its customers. Substantial know-how, innovative developments and its ability to think and act in a market-oriented way has positioned Söhngen as a leading supplier of first aid and emergency medicine products throughout Europe.
In order to support further expansion of the business Steadfast Capital Fund IV SCS, SICAV-RAIF has acquired a stake in Söhngen in June 2019. Together with Udo Frankenfeld, the CEO of Söhngen, Steadfast Capital will support the group’s international expansion as well as the ongoing strategic development of the company and its employees.
Borromin will work closely with management and, together with the management, has identified several growth-oriented projects, in particular: